(Q33739351)

English

Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Triple-negative breast cancer and PTEN (phosphatase and tensin homologue) loss are predictors of BRCA1 germline mutations in women with early-onset and familial breast cancer, but not in women with isolated late-onset breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

author name string

Sze-Yee Phuah

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lai-Meng Looi

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Norhashimah Hassan

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Anthony Rhodes

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sarah Dean

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nur Aishah Mohd Taib

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Cheng-Har Yip

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Soo-Hwang Teo

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

2 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Breast Cancer Research

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R142

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1186/bcr3347

0 references

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Synthetic lethal approaches to breast cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Incorporating tumour pathology information into breast cancer risk prediction algorithms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Optimal selection of individuals for BRCA mutation testing: a comparison of available methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4053128

21 June 2018

Update on the Manchester Scoring System for BRCA1 and BRCA2 testing

1 reference

https://api.crossref.org/works/10.1186%2FBCR3347

21 January 2018

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR3347

21 January 2018

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

1 reference

https://api.crossref.org/works/10.1186%2FBCR3347

21 January 2018

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1 reference

https://pubmed.ncbi.nlm.nih.gov/23116406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23116406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23116406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23116406

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/BCR3347

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33739351&oldid=1988690620"